Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$9.82 Billion
Market Cap Rank
#1718 Global
#1266 in USA
Share Price
$88.16
Change (1 day)
+2.80%
52-Week Range
$51.89 - $96.71
All Time High
$96.71
About

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral… Read more

Globus Medical (GMED) - Total Liabilities

Latest total liabilities as of September 2025: $696.82 Million USD

Based on the latest financial reports, Globus Medical (GMED) has total liabilities worth $696.82 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Globus Medical - Total Liabilities Trend (2010–2024)

This chart illustrates how Globus Medical's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Globus Medical Competitors by Total Liabilities

The table below lists competitors of Globus Medical ranked by their total liabilities.

Company Country Total Liabilities
Hyundai Motor Company
F:HYU
Germany €194.57 Trillion
ENN Energy Holdings Ltd
PINK:XNGSY
USA $52.11 Billion
Donaldson Company Inc
NYSE:DCI
USA $1.51 Billion
Builders FirstSource Inc
NYSE:BLDR
USA $7.11 Billion
Biwin Storage Technology Co. Ltd. A
SHG:688525
China CN¥7.34 Billion
Akzo Nobel N.V
OTCQX:AKZOF
USA $9.13 Billion
Evolution AB (publ)
PINK:EVGGF
USA $1.44 Billion
OGE Energy Corporation
NYSE:OGE
USA $9.39 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down Globus Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Globus Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Globus Medical (2010–2024)

The table below shows the annual total liabilities of Globus Medical from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 $1.07 Billion -1.26%
2023-12-31 $1.09 Billion +373.61%
2022-12-31 $229.75 Million +6.43%
2021-12-31 $215.88 Million +24.65%
2020-12-31 $173.19 Million +33.61%
2019-12-31 $129.62 Million +12.57%
2018-12-31 $115.15 Million +4.00%
2017-12-31 $110.72 Million +15.87%
2016-12-31 $95.56 Million -19.55%
2015-12-31 $118.78 Million +0.58%
2014-12-31 $118.09 Million +25.71%
2013-12-31 $93.94 Million +54.94%
2012-12-31 $60.63 Million +29.24%
2011-12-31 $46.91 Million +22.24%
2010-12-31 $38.38 Million --